Petco Health and Wellness Bolsa (NASDAQ: WOOF)

Petco Health and Wellness (NASDAQ:WOOF) Bolsa

PETCO HEALTH AND WELLNESS CO

Petco Health and Wellness

Petco Health and Wellness Co Inc is a pet health and wellness company focused on improving the lives of pets, pet parents, and its partners with approximately 1,423 pet care centers offering pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.

Petco Health and Wellness Company, Inc. - Class A Common Stock

Petco Health and Wellness Co Inc

WOOF

WIIM

AMZN

BBWI

BIRK

BURL

CANG

CHWY

CPRI

CVNA

DECK

DLTR

FIVE

REAL

SFIX

SHOO

SHOT

TSCO

ULTA

URBN

Shares of e-commerce, retail, and apparel stocks are trading lower following greater-than-expected inflation data measured through the PCE price index for February, while personal spending missed estimates. Additionally, recent tariff announcements may be weighing on equities.

Throughout the last three months, 7 analysts have evaluated Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $3.85, a high estimate of $5.00, and a low estimate of $2.75. This current average has decreased by 28.17% from the previous average price target of $5.36. 
<img src="https://www.benzinga.com/files/images/story/2025/1743105628_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Petco Health and Wellness among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kate McShane</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$4.48</td>
<td>$4.00</td>
</tr>
<tr>
<td>Michael Lasser</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$3.25</td>
<td>$5.50</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$4.00</td>
<td>$6.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$4.00</td>
<td>$6.00</td>
</tr>
<tr>
<td>Justin Kleber</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$3.50</td>
<td>$5.00</td>
</tr>
<tr>
<td>Steven Zaccone</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$2.75</td>
<td>$5.00</td>
</tr>
<tr>
<td>Simeon Gutman</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$5.00</td>
<td>$6.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Petco Health and Wellness. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Petco Health and Wellness compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Petco Health and Wellness's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Petco Health and Wellness's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/WOOF/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Petco Health and Wellness analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>All You Need to Know About Petco Health and Wellness</h2>
Petco Health and Wellness Co Inc is a pet health and wellness company focused on improving the lives of pets, pet parents, and its partners with approximately 1,423 pet care centers offering pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.
<h3>Unraveling the Financial Story of Petco Health and Wellness</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Petco Health and Wellness displayed positive results in 3 months. As of 31 October, 2024, the company achieved a solid revenue growth rate of approximately 1.16%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Petco Health and Wellness's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -1.1%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Petco Health and Wellness's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -1.48%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -0.32%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.66, caution is advised due to increased financial risk.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

What Analysts Are Saying About Petco Health and Wellness Stock

Shares of Petco Health and Wellness Company Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) skyrocketed in early trading on Thursday, despite the company reporting <a href="https://www.benzinga.com/news/earnings/25/03/44503412/petco-shares-soar-despite-worse-than-expected-q4-results">disappointing fourth-quarter results</a>.
The company reported its results amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
Wedbush On Petco Health and Wellness Company
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5846ee57ee7bf6000154d134/seth-basham">Analyst Seth Basham</a> maintained an Outperform rating, while reducing the price target from $6 to $4.
Petco Health and Wellness Company's comps rose 0.5% in the quarter, slightly below consensus of 0.8%, while decelerating from the previous quarter's 1.8%, Basham said in a note. The company's gross margins expanded by 180 basis points to 38%, beating the consensus of 37.8%, he added.
"The results demonstrate solid progress under new CEO Joel Anderson to return the business model to retail operating excellence and drive structural costs out," the analyst wrote. While management guided to a decline in net sales, their adjusted EBITDA guidance came in at $82 million-$83 million, above consensus of $78.2 million, he stated.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
RBC Capital Markets On Petco Health and Wellness Company
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/61aa12038d115900012d093d/steven-shemesh">Analyst Steven Shemesh</a> reiterated an Outperform rating, while cutting the price target from $6 to $4.
Petco Health and Wellness Company's comps decelerated sequentially, expenses rose, and market share contracted in the quarter, Shemesh said. Management presented "a three-phased approach to reset its economic model and improve profitability," he added.
The first phase of improving its operating model and leadership team is complete, while the second phase of improving margins "through merchandising, sharpening approach to pricing/promotions, optimizing store fleet and overall cost discipline across the business" is currently underway, the analyst wrote. The third phase of testing growth initiatives to drive revenue growth will begin in late 2025, he stated.
Goldman Sachs On Petco Health and Wellness Company
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58580bcbee7bf60001bcfa29/kate-mcshane">Analyst Kate McShane</a> reaffirmed a Buy rating, while raising the price target from $4.00 to $4.48.
Petco Health and Wellness Company's net revenues declined by 7.3% year-on-year to $1.552 billion, missing the consensus of $1.561 billion, McShane said. The management team "is focused on retail fundamentals to strengthen the foundation for Petco to return to sustainable and profitable growth," he wrote.
The company closed 25 net locations in 2024 and plans to close another 20 to 30 net locations in 2025, "many of which were unprofitable and will help drive better adj EBITDA," the analyst stated. Management guided to adjusted EBITDA profitability growth for 2025, he further stated.
WOOF Price Action: Shares of Petco Health and Wellness Company had risen by 28.6% to $3.14 at the time of publication on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/insights/analyst-ratings/25/02/43568843/forecasting-the-future-6-analyst-projections-for-tradeweb-markets"> </a><a href="https://www.benzinga.com/news/earnings/25/03/44491397/dollar-tree-q4-earnings-surpass-estimates-unloads-family-dollar-for-1b">These Analysts Boost Their Forecasts On Chewy Following Earnings Beat</a></li>
</ul>
Photo: Shutterstock

Petco Analysts See Turnaround Progress With Higher Margins, Profitability Focus

Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) revealed a new partnership with Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">on Thursday.</a>
The collaboration brings Petco&#8217;s range of pet essentials to the Uber Eats platform, making it easier for pet owners to access a variety of <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/b44513660/petco-joins-uber-eats-for-nationwide-on-demand-delivery" rel="noreferrer noopener">pet food, toys, treats, and other products.</a>
The company&#8217;s shares are trading higher on Thursday. According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, WOOF stock has gained over 44% in the past year. Investors can gain exposure to the stock via&nbsp;ProShares Pet Care ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/PAWZ#BATS">PAWZ</a>).
This partnership provides a solution for busy pet parents. They can now browse Petco&#8217;s selection of high-quality pet products and have them delivered right to their door, at their convenience.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44519736/why-is-autoimmune-disease-focused-nkarta-stock-trading-higher-on-thursday" rel="noreferrer noopener">Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday?</a>
Steve Janowiak, Petco&#8217;s VP of Digital, expressed excitement about the partnership, emphasizing the company&#8217;s commitment to making pet care products more accessible.
The collaboration also introduces Petco items like the YOULY spring collection and the &#8220;Started as a Bottle&#8221; line made from recycled materials.
This move also signals Uber Eats&#8217; ongoing expansion of its retail offerings, aiming to become a one-stop shop for groceries, household goods, and now pet care products.
Yesterday, Petco reported a slight miss in its fourth-quarter&nbsp;earnings and forecasted low single-digit declines<a target="_blank" href="https://www.benzinga.com/news/earnings/25/03/44503412/petco-shares-soar-despite-worse-than-expected-q4-results" rel="noreferrer noopener"> in revenue for first-quarter and fiscal 2025.</a>
Petco reported GAAP losses of five cents per share, which missed the analyst consensus estimate for losses of two cents. Quarterly revenue came in at $1.52 billion, missing the consensus estimate of $1.56 billion. Comparable sales increased 0.5% year-over-year.
Price Action: WOOF shares are trading higher by 29.4% to $3.156 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44511565/ge-aerospace-lands-major-korean-air-deal-genx-and-ge9x-engines-to-power-new-boeing-fleet" target="_blank" rel="noreferrer noopener">GE Aerospace Lands Major Korean Air Deal: GEnx And GE9X Engines To Power New Boeing Fleet</a></li>
</ul>
Photo via Shutterstock.

Equities

News

Contracts

Markets

Movers

General

PAWZ

UBER

What's Going On With Petco Health Stock Today?

<h3>Gainers</h3>
<ul>
<li>Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) stock rose 28.7% to $3.14 during Thursday's regular session. The market value of their outstanding shares is at $865.5 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Damon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMN#NASDAQ">DMN</a>) stock rose 20.3% to $0.05. The market value of their outstanding shares is at $7.4 million. </li>
<li>Yoshiharu Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YOSH#NASDAQ">YOSH</a>) stock moved upwards by 15.48% to $17.15. The company's market cap stands at $29.6 million. </li>
<li>Connexa Sports Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YYAI#NASDAQ">YYAI</a>) stock rose 13.58% to $0.88. The company's market cap stands at $12.8 million. As per the news, the Q3 earnings report came out 3 days ago. </li>
<li>LightInTheBox Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LITB#NYSE">LITB</a>) stock moved upwards by 11.86% to $1.32. The company's market cap stands at $146.7 million. As per the news, the Q4 earnings report came out 2 days ago. </li>
<li>Chegg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) shares increased by 11.63% to $0.72. The company's market cap stands at $76.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lixiang Education Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) stock declined by 28.6% to $13.0 during Thursday's regular session. The market value of their outstanding shares is at $15.1 million. </li>
<li>GameStop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) shares declined by 21.42% to $22.29. The company's market cap stands at $9.9 billion. As per the press release, Q4 earnings came out 2 days ago. </li>
<li>Mullen Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) stock declined by 16.77% to $0.17. </li>
<li>Genius Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) stock decreased by 10.94% to $0.28. The company's market cap stands at $21.9 million. </li>
<li>Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) shares fell 10.48% to $13.51. The company's market cap stands at $1.1 billion. </li>
<li>Lottery.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRY#NASDAQ">LTRY</a>) shares decreased by 10.09% to $0.94. The company's market cap stands at $11.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADNT

CHGG

LITB

LTRY

LXEH

MULN

YOSH

Connexa Sports Technologies Inc. - Common Stock

YYAI

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

Goldman Sachs analyst Kate McShane maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Buy and raises the price target from $4 to $4.48.

Price Target

Goldman Sachs Maintains Buy on Petco Health and Wellness, Raises Price Target to $4.48

UBS analyst Michael Lasser maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Neutral and lowers the price target from $5.5 to $3.25.

UBS Maintains Neutral on Petco Health and Wellness, Lowers Price Target to $3.25

RBC Capital analyst Steven Shemesh maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Outperform and lowers the price target from $6 to $4.

RBC Capital Maintains Outperform on Petco Health and Wellness, Lowers Price Target to $4

Petco Health and Wellness shares are trading higher following Q4 earnings.

U.S. stocks were lower, with the Dow Jones index falling around 0.2% on Thursday.
Shares of Concentrix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) rose sharply during Thursday's session after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance <a href="https://in.benzinga.com/news/earnings/25/03/44504468/concentrix-shares-pop-on-strong-q1-results-raised-revenue-guidance">above estimates</a>.
Concentrix reported quarterly earnings of $2.79 per share, which beat the analyst consensus estimate of $2.58. Quarterly revenue came in at $2.37 billion, which beat the analyst consensus estimate of $2.36 billion and is down slightly from revenue of $2.4 billion from the same period last year.
Concentrix raised its fiscal 2025 reported revenue outlook from between $9.47 billion and $9.61 billion to between $9.49 billion and $9.635 billion, versus the $9.54 billion estimate.
Concentrix shares jumped 27% to $58.28 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Soleno Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNO#NASDAQ">SLNO</a>) shares jumped 40.3% to $68.72 after the company announced it secured FDA approval for its first commercial drug for a rare genetic disorder.</li>
<li>Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) gained 32% to $3.2399 following fourth-quarter results.</li>
<li>Hertz Global Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>) rose 23.5% to $4.2650.</li>
<li>Jiayin Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFIN#NASDAQ">JFIN</a>) climbed 20.2% to $14.55 following fourth-quarter results.</li>
<li>Avis Budget Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>) gained 19.7% to $73.72.</li>
<li>MillerKnoll, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) shares climbed 11.7% to $20.45 after reporting third-quarter results.</li>
<li>Edgewise Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWTX#NASDAQ">EWTX</a>) rose 11.6% to $24.85.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) gained 11% to $3.0850.</li>
<li>iQIYI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IQ#NASDAQ">IQ</a>) shares rose 8% to $2.4150.</li>
<li>Zai Lab Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZLAB#NASDAQ">ZLAB</a>) gained 6.4% to $36.09. Cantor Fitzgerald analyst Li Watsek reiterated Zai Lab with an Overweight rating.</li>
<li>Dollar Tree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) rose 5.5% to $73.08. Telsey Advisory Group analyst Joseph Feldman maintained Dollar Tree with a Market Perform and raised the price target from $75 to $82.</li>
<li>Ollie&#8217;s Bargain Outlet Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>) gained 4.7% to $113.24.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44492633/jim-cramer-palantir-is-a-winner-recommends-selling-this-tech-stock">Jim Cramer: Palantir Is A &#8216;Winner,&#8217; Recommends Selling This Tech Stock</a></li>
</ul>

Intraday Update

Trading Ideas

CNXC

EWTX

IBRX

JFIN

MLKN

OLLI

SLNO

ZLAB

Concentrix Posts Better-Than-Expected Earnings, Joins Soleno Therapeutics, Petco Health and Wellness, MillerKnoll And Other Big Stocks Moving Higher On Thursday

Wedbush analyst Seth Basham maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Outperform and lowers the price target from $6 to $4.

Wedbush Maintains Outperform on Petco Health and Wellness, Lowers Price Target to $4

Baird analyst Justin Kleber maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Neutral and lowers the price target from $5 to $3.5.

Baird Maintains Neutral on Petco Health and Wellness, Lowers Price Target to $3.5

Today Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) and Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) announced a new partnership that brings Petco's wide selection of pet essentials to the Uber Eats platform, making it easier than ever for pet parents to get what they need, when they need it. With all Petco locations in the contiguous United States now available on Uber Eats, customers can shop for on-demand or scheduled delivery of pet food, toys, treats, and other essentials—all at the tap of a button.
Starting today, pet parents can browse and purchase Petco's curated assortment of high-quality products directly through the Uber Eats app, with convenient delivery options that fit their busy schedules. To celebrate the launch, new and existing Uber Eats users can take advantage of an exclusive promotion for their furry, finned, feathered, or scaly companions: 40% off orders of $50 or more (up to $30)† and—as always—Uber One membership unlocks exclusive benefits, including $0 Delivery Fees on eligible orders††.

Petco Joins Uber Eats For Nationwide On-Demand Delivery

Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) released its fourth-quarter results after Wednesday's closing bell. Here's a look at the<a href="https://www.benzinga.com/pressreleases/25/03/n44502527/petco-health-wellness-company-inc-reports-fourth-quarter-and-full-year-2024-financial-results"> details from the report. </a>
The Details: Petco Health and Wellness reported GAAP losses of five cents per share, which missed the analyst consensus estimate for losses of two cents. Quarterly revenue came in at $1.52 billion, missing the consensus estimate of $1.56 billion. Comparable sales increased 0.5% year-over-year.
Read Next: <a href="https://www.benzinga.com/news/global/25/03/44494896/us-adds-50-chinese-entities-to-export-restriction-list-curtailing-access-to-nvidia-amd-chips">US Adds 50 Chinese Entities To Export Restriction List Curtailing Access To Nvidia, AMD Chips</a>
&#8220;Our results in the fourth quarter demonstrate the progress we&#8217;ve made to return Petco to retail operating excellence,&#8221; said Joel Anderson, Petco&#8217;s CEO. &#8220;While there is more work ahead, I am confident our new leadership team is well-positioned to build on this early momentum, deliver double-digit adjusted EBITDA improvement in 2025 and set the business up for sustainable profitable growth.&#8221;
Outlook: Petco sees first-quarter and fiscal 2025 net revenue down by low single digits year-over-year. 
WOOF Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Petco shares were up 13.11% after hours at $2.76 on Wednesday.  
Read More:
<ul>
<li>&nbsp;<a href="https://www.benzinga.com/news/global/25/03/44477467/trumps-tariffs-on-buyers-of-venezuelan-oil-could-boost-energy-sector-exxon-mobil-stock">Trump&#8217;s Tariffs On Buyers Of Venezuelan Oil Could Boost Energy Sector, Exxon Mobil Stock&nbsp;</a></li>
</ul>
Photo: Shutterstock

Earnings

After-Hours Center

Petco Shares Soar Despite Worse-Than-Expected Q4 Results

Petco Health and Wellness shares are trading higher. The company reported Q4 financial results.

Guidance

Petco Sees Q1 Net Revenue Down Low-Single Digits YoY

Earnings Misses

Petco Health and Wellness Q4 2024 GAAP EPS $(0.05) Misses $(0.02) Estimate, Sales $1.522B Miss $1.561B Estimate

<h3>Companies Reporting Before The Bell</h3>
• Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) is estimated to report quarterly loss at $5.00 per share on revenue of $5.60 million. 
• Dollar Tree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) is projected to report quarterly earnings at $2.18 per share on revenue of $8.23 billion. 
• Chewy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) is projected to report quarterly earnings at $0.05 per share on revenue of $3.20 billion. 
• Titan America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTAM#NYSE">TTAM</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $384.72 million. 
• Cintas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) is likely to report quarterly earnings at $1.06 per share on revenue of $2.60 billion. 
• SailPoint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIL#NASDAQ">SAIL</a>) is expected to report quarterly loss at $0.03 per share on revenue of $202.71 million. 
• REX American Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REX#NYSE">REX</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $152.00 million. 
• CollPlant Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLGN#NASDAQ">CLGN</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $358 thousand. 
• Target Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TH#NASDAQ">TH</a>) is expected to report quarterly earnings at $0.07 per share on revenue of $80.10 million. 
• JinkoSolar Holding Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JKS#NYSE">JKS</a>) is estimated to report quarterly loss at $0.46 per share on revenue of $3.59 billion. 
• BRP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOOO#NASDAQ">DOOO</a>) is expected to report quarterly earnings at $0.62 per share on revenue of $1.35 billion. 
• Canaan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) is expected to report quarterly loss at $0.14 per share on revenue of $88.50 million. 
• Precision BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>) is expected to report quarterly loss at $2.94 per share on revenue of $4.28 million. 
• Cheetah Mobile (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMCM#NYSE">CMCM</a>) is expected to report earnings for its fourth quarter. 
• Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) is projected to report quarterly earnings at $1.48 per share on revenue of $1.51 billion. 
• Zhihu (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZH#NYSE">ZH</a>) is projected to report earnings for its fourth quarter. 
<h3>Companies Reporting After The Bell</h3>
• Snail (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNAL#NASDAQ">SNAL</a>) is estimated to report earnings for its fourth quarter. 
• Integra Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ITRG#AMEX">ITRG</a>) is likely to report earnings for its fourth quarter. 
• TAT Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TATT#NASDAQ">TATT</a>) is likely to report earnings for its fourth quarter. 
• Envela (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELA#AMEX">ELA</a>) is likely to report quarterly earnings at $0.05 per share on revenue of $40.63 million. 
• 3D Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDD#NYSE">DDD</a>) is projected to report quarterly loss at $0.11 per share on revenue of $114.96 million. 
• BioCardia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCDA#NASDAQ">BCDA</a>) is projected to report quarterly loss at $0.87 per share on revenue of $20 thousand. 
• Oxbridge Re Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXBR#NASDAQ">OXBR</a>) is projected to report earnings for its fourth quarter. 
• Durect (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRRX#NASDAQ">DRRX</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $6.91 million. 
• Journey Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DERM#NASDAQ">DERM</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $14.21 million. 
• Zepp Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZEPP#NYSE">ZEPP</a>) is expected to report earnings for its fourth quarter. 
• FGI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGI#NASDAQ">FGI</a>) is projected to report quarterly loss at $0.03 per share on revenue of $33.09 million. 
• Jefferies Financial Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEF#NYSE">JEF</a>) is projected to report quarterly earnings at $1.13 per share on revenue of $1.97 billion. 
• Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) is estimated to report quarterly loss at $0.08 per share on revenue of $2.10 million. 
• H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) is projected to report quarterly earnings at $0.63 per share on revenue of $797.68 million. 
• Dyadic International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYAI#NASDAQ">DYAI</a>) is expected to report quarterly loss at $0.06 per share on revenue of $1.35 million. 
• Usio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USIO#NASDAQ">USIO</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $21.40 million. 
• Verint Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNT#NASDAQ">VRNT</a>) is estimated to report quarterly earnings at $1.27 per share on revenue of $276.82 million. 
• Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) is estimated to report quarterly earnings at $3.01 per share on revenue of $2.47 billion. 
• Spruce Power Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPRU#NYSE">SPRU</a>) is projected to report earnings for its fourth quarter. 
• Steelcase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCS#NYSE">SCS</a>) is likely to report quarterly earnings at $0.21 per share on revenue of $790.90 million. 
• Guardian Pharmacy Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRDN#NYSE">GRDN</a>) is projected to report quarterly earnings at $0.20 per share on revenue of $320.52 million. 
• Perspective Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CATX#AMEX">CATX</a>) is expected to report quarterly loss at $0.26 per share on revenue of $232 thousand. 
• MillerKnoll (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) is projected to report quarterly earnings at $0.44 per share on revenue of $918.88 million. 
• Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $87.50 million. 
• Inventiva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVA#NASDAQ">IVA</a>) is estimated to report earnings for its Fiscal Year 2024. 
• Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) is projected to report quarterly earnings at $0.01 per share on revenue of $1.56 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALUR

ALVO

BCDA

CATX

CLGN

CMCM

CTAS

DERM

DOOO

DRRX

DTIL

DYAI

GRDN

ITRG

MVIS

OXBR

PAYX

SAIL

SNAL

Spruce Power Holding Corporation Class A Common Stock

SPRU

TATT

TTAM

USIO

VRNT

ZEPP

Earnings Scheduled For March 26, 2025

LULU

Shares of retail, apparel, and e-commerce companies are trading higher amid overall market strength on reports of potentially narrowed or targeted tariffs, which may be easing investor concerns.

Citigroup analyst Steven Zaccone maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Neutral and lowers the price target from $5 to $2.75.

Citigroup Maintains Neutral on Petco Health and Wellness, Lowers Price Target to $2.75

Press Releases

Petco Health and Wellness Company, Inc. to Host Second Quarter 2024 Earnings Conference Call on September 10, 2024

Petco Health + Wellness Company, Inc. Reports Second Quarter 2024 Earnings Results

Petco Health and Wellness Company, Inc. to Host Third Quarter 2024 Earnings Conference Call on December 5, 2024

Petco Names Joe Venezia Chief Revenue Officer

Petco Health + Wellness Company, Inc. Reports Third Quarter 2024 Earnings Results

PETCO STRENGTHENS LEADERSHIP TEAM WITH APPOINTMENT OF THREE PROVEN EXECUTIVES

Petco Health and Wellness Company, Inc. to Host Fourth Quarter 2024 Earnings Conference Call on March 26, 2025

Petco Health + Wellness Company, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Petco Health + Wellness Company, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Petco joins Uber Eats for Nationwide On-Demand Delivery

Academy Sports and Outdoors, Inc. - Common Stock

Academy Sports

BARK

Build-A-Bear Workshop

Bath & Body Works

Barnes & Noble Education, Inc Common Stock

Barnes & Noble Education

Chewy

Dick's Sporting Goods

Envela

National Vision Holdings, Inc. - Common Stock

National Vision Holdings

Five Below

1-800-FLOWERS.COM, Inc. - Class A Common Stock

1-800-Flowers.com

Grove Collaborative Holdings, Inc. Class A Common Stock

Grove Collaborative Hldgs

MarineMax

Leslies

PetMed Express

Park Ha Biological Technology Co., Ltd. - ordinary shares

Park Ha Biological Tech

Sally Beauty Holdings, Inc. (Name to be changed from Sally Holdings, Inc.) Common Stock

Comments

Petco Health and Wellness

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL